OMDA Omada Health (OMDA) Q2 FY26 earnings call
Omada Health reported a record-setting Q2 FY26, driven by strong revenue growth, significant margin expansion, and increased member engagement across its cardiometabolic programs. The company announced a planned CEO transition, with President Wei-Li Hsiao succeeding co-founder Sean Duffy in January 2027, signaling a focus on leveraging GLP-1s, AI, and expanded commercial reach to drive future growth. Management raised full-year guidance, anticipating continued profitability despite expected seasonal moderation in the second half.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.